Reimbursement
Physician pay in final rule is untenable, providers say, as they laud the delay of MIPS policy and extension of telehealth flexibilities.
The company cites clinical expertise and service capabilities across the company, boosted by "disciplined execution."
CMS had originally proposed a 2.2% decrease to account for the permanent behavior assumption adjustment.
A number of factors contributed to the company's financial performance, including the August launch of Cordavis and its MA offerings.
Stop APM bonus cut and MIPS penalties in MACRA and Medicare physician payment decreases, AMA says.
Final rule increases payment for certain new renal dialysis drugs and biological products.
HHS released information blocking proposed rule with monetary disincentives to increase electronic health information sharing.
Payers have seen success in improving health outcomes by taking a holistic approach to member interventions, says Leah Dewey, vice president of Cotiviti.
Healthcare leaders will confront sustained upward pressure on compensation for these roles moving forward, report finds.
The associations' primary recommendation is to retire CMS' Severe Sepsis/Septic Shock Management Bundle.